Assenagon Asset Management’s 10x Genomics TXG Stock Holding History

Assenagon Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$559K	Hold	14,577	–	–	﹤0.01%	1060
2026 Q1	$309K	Sell	14,577 -2,859	-16%	-$57.2K	﹤0.01%	1051
2025 Q4	$284K	Buy	17,436 +2,859	+20%	+$43.2K	﹤0.01%	1096
2025 Q3	$170K	Sell	14,577 -1,696,984	-99%	-$22.1M	﹤0.01%	1138
2025 Q2	$19.8M	Sell	1,711,561 -23,073	-1%	-$210K	0.03%	352
2025 Q1	$15.1M	Sell	1,734,634 -97,373	-5%	-$1.23M	0.03%	363
2024 Q4	$26.3M	Buy	+1,832,007	New	+$28.9M	0.04%	312
2024 Q2	–	Sell	-63,400	Closed	-$2.38M	–	1496
2024 Q1	$2.38M	Buy	63,400 +45,814	+261%	+$2.01M	0.01%	829
2023 Q4	$984K	Buy	+17,586	New	+$765K	﹤0.01%	1099

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Assenagon Asset Management's TXG Position: Q2 2026 in Review

Assenagon Asset Management held its 10x Genomics (TXG) position steady in Q2 2026 at 14,577 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Assenagon Asset Management first reported a position in TXG in Q4 2023 and has held it in 9 quarters since. The position peaked at $26.3M in Q4 2024. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Assenagon Asset Management held 14,577 shares of 10x Genomics worth $559K as of Q2 2026.
Assenagon Asset Management left its 10x Genomics share count unchanged in Q2 2026.
10x Genomics made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1060 holding.
Assenagon Asset Management first reported a position in 10x Genomics in Q4 2023 and has held it in 9 quarters since.
Assenagon Asset Management's 10x Genomics position peaked at $26.3M in Q4 2024.
390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.